Mediso Medical Imaging Systems with headquarters in Budapest is a dynamic supplier of Nuclear Medicine and modern Hybrid Imaging techniques to the health care and medical research institutions of the world. The company was founded in 1990 by experts of the largest research and manufacturing company of the region which has been engaged of nuclear equipment manufacturing since 1960.
The business strength and perspective of Mediso is based on its R&D activity. To keep production on the leading edge continuous development of new products is a must. The company's declared aim is to develop competitive Nuclear Medicine and Hybrid Imaging equipment applying the most up-to-date technology. More than 50% of Mediso employees are engaged with R&D. (75% of Mediso employees hold higher academic degrees.)
A number of co-operations have been formed with hospitals, clinics and scientific institutions ensuring that the developed technology is in accordance with the needs of Mediso's clinical partners. Production the high quality unique systems designed with top level engineering and elaborated solid solutions are implemented to physical reality by the manufacturing section of Mediso.
Carefully selected suppliers of quality parts and specialised high-precision subsystem manufacturers are key factors in the quality of final product integration.
The high quality unique systems designed with top level engineering and elaborated solid solutions are implemented to physical reality by the manufacturing section of Mediso. Carefully selected suppliers of quality parts and specialised high-precision subsystem manufacturers are key factors in the quality of final product integration.
The Mediso-affiliated USA, German and Polish subsidiaries and the wordwide distributor network ensures close contact with our customers and offers quick response for their requests. More than 1550 Mediso cameras are installed in more than 100 countries worldwide.
Mediso operates two PET-CT and nuclear medicine centres at the University of Debrecen and in Budapest. The strong university and clinical background gives Mediso a first-hand clinical experience and important application feedback.
Since 1990, Mediso is creating new technologies, and molecular imaging systems.
Clinical and pre-clinical solutions for hospitals, clinics and scientific institution
George Hevesy received Nobel Prize for nuclear tracer theory
Gamma Works released its first NM imager with digital processing Gamma Works released its first NM imager with digital processing s released its first NM imager with digital processing processing Gamma Works released its first NM imager with digital proce
Foundation of Mediso
Introduction of the first Mediso gamma camera
Release of the first SPECT camera Nucline™ X-Ring-R
Mediso acquired the NM profile of Gamma Works
Launch of the Nucline™ SPIRIT DH-V variable angle dual head camera
Nucline X-ring/4R, 4-head dedicated brain SPECT
Establishing Mediso Gmbh in Munster, Germany
Launching the first Mediso preclinical system the nanoSPECT/CT
Production of the first Mediso clinical SPECT/CT. Mediso takes on NM clinical diagnostic service profile acquiring ScanoMed Ltd.
Launch of AnyScan® multimodality clinical imaging family
Launch of nanoScan® PET/CT, world’s first ever sub-mm resolution preclinical PET/CT
Introduction of the nanoScan® PET/MRI 1T, world’s first ever commercial preclinical PET/MRI
Establishing Mediso USA in Boston, MA
MultiScan® LFER 150, world’s first sub-mm resolution portable PET/CT
AnyScan® TRIO SPECT, introduction of triple SPECT detector family
Opening of new HQ in Budapest, Hungary
Introducing the nanoScan® PET/MRI 3T world’s first superconducting preclinical PET/MRI